CIK 0001598646
- Non-accelerated filer
- Smaller reporting company
Minerva Neurosciences, Inc.
Sign in to watch- Ticker
- NERV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 260784194
- Phone
- +1 617-600-7373
- Business address
- 1500 DISTRICT AVENUE, BURLINGTON, MA, 01803
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-12-04 | Reilly Joseph H. SVP & Chief Operating Officer | Grant or award · Stock Option (right to buy) | +69,000 | 69,000 | ||
| 2015-12-04 | Race Geoff EVP & Chief Financial Officer | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2015-12-04 | Vandervelpen Nico Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2015-12-04 | Luthringer Remy President & CEO | Grant or award · Stock Option (right to buy) | +320,000 | 320,000 | ||
| 2015-11-02 | Kupfer David Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 |
Page 16 of 16 · 305 trades